Home Tags JPM17
Here are 7 topics from healthcare that could become household names by the end of the year.
We asked biotech startups and early-stage companies, "Has there been a 'Theranos effect' on biotech investing?"
2017 will be a make-or-break year for neuroscience.
A Nevada woman died from a bug that resisted 26 antibiotics — here’s why it’s so hard to develop new ones
Antibiotic resistance is a growing problem. Here's why it's so hard to make new antibiotics to tackle the problem head-on.
Trump's comments accusing drug companies of ""getting away with murder" got under a lot of industry leaders' skin.
HealthTap, a startup that connects doctors to patients via video, voice, text messaging, launched a system called Dr. AI to help "triage" patients.
There's a lack of female leaders in drug companies — but female CEOs are feeling optimistic about the future.
The biggest healthcare investor conference starts this week — here are the 5 things we expect to get out of it
From the political environment to the "next big thing" — here are some of the key themes we'll be asking about at JPMorgan's healthcare conference next week.
Gene-sequencing company Illumina is teaming up Watson Health to put Watson's artificial intelligence to work analyzing Illumina's solid tumor sequencing panel.